http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20120129777-A
Outgoing Links
Predicate | Object |
---|---|
classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10S424-826 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-522 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-0275 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-112 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-00 |
filingDate | 2012-05-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2012-11-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | KR-20120129777-A |
titleOfInvention | Probiotic vaccine composition for preventing Salmonellosis comprising a mutant strain of attenuated, immunopotentiated Salmonella enteritidis |
abstract | The present invention provides attenuated strains of Salmonella enteritidis which have lost host invasion-related pathogen genes and their functions; Immunopotentiated mutation strains of Salmonella enteritidis; Or it relates to a live vaccine composition for the prevention of Salmonellosis comprising a combination thereof and a method for preventing egg-flood contamination of Salmonella enteritidis bacteria in birds by inoculating them. Attenuated, immune-enhanced mutant strains according to the present invention can be conveniently orally inoculated when administered to poultry, and in this case can provide more effective preventive capacity, two genes are deleted at the same time, when administered to poultry, pathogenic recovery Low protection, excellent defense and safe. In addition, the host mucosa cell adhesion and invasiveness, immunity is not only excellent, but also does not cause egg contamination by the vaccine is safe. In addition, since the mixed inoculation of the vaccine composition according to the present invention can effectively protect against infection and egg contamination caused by wild strains, the attenuated and immune-enhanced strains of the present invention can be usefully used as a probiotic vaccine composition for preventing salmonella. Can be. |
isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20170010540-A |
priorityDate | 2011-05-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 174.